A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
Reason given: Company shifted focus
Key facts
- Where
- Ventura, United StatesSee the site
Where in United States
- ProgenaBiomeVentura, United StatesNo longer taking part
Trial details
- Who runs it
- ProgenaBiome
- Trial code
- NCT04100616
- Record updated
- 5 June 2025
- Original description
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding obesity.Read full original descriptionShow less
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records regarding obesity.
Inclusion: Signed informed consent by patient; Male or female patients age 18 and older; Diagnosis of obesity based on Body Mass Index (BMI) of 30 or greater.
Exclusion: Treatment with antibiotics within two weeks prior to screening; Treatment with probiotics within six weeks prior to screening; Participation in any experimental drug protocol within the past 12 weeks; Treatment with total parenteral nutrition; History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy; Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial; Refusal by patient to sign informed consent form; Postoperative stoma, ostomy, or ileoanal pouch; Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study.